ATE500226T1 - Aripiprazolhemifumarat und verfahren zu dessen herstellung - Google Patents

Aripiprazolhemifumarat und verfahren zu dessen herstellung

Info

Publication number
ATE500226T1
ATE500226T1 AT07818336T AT07818336T ATE500226T1 AT E500226 T1 ATE500226 T1 AT E500226T1 AT 07818336 T AT07818336 T AT 07818336T AT 07818336 T AT07818336 T AT 07818336T AT E500226 T1 ATE500226 T1 AT E500226T1
Authority
AT
Austria
Prior art keywords
production
aripiprazole hemifumarate
hemifumarate
aripiprazole
crystalline
Prior art date
Application number
AT07818336T
Other languages
English (en)
Inventor
Marjo Merslavic
Urska Gojak
Matej Smrkolj
Sergeja Bombek
Marko Stefanic
Anamarija Vajs
Vesna Kroselj
Original Assignee
Krka Tovarna Zdravil D D Novo Mesto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SI200600219A external-priority patent/SI22381A/sl
Priority claimed from SI200700135A external-priority patent/SI22544A/sl
Application filed by Krka Tovarna Zdravil D D Novo Mesto filed Critical Krka Tovarna Zdravil D D Novo Mesto
Application granted granted Critical
Publication of ATE500226T1 publication Critical patent/ATE500226T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT07818336T 2006-09-22 2007-09-21 Aripiprazolhemifumarat und verfahren zu dessen herstellung ATE500226T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SI200600219A SI22381A (sl) 2006-09-22 2006-09-22 Aripiprazol hemifumarat, njegova kristalna oblikain postopki za njegovo pripravo
SI200700135A SI22544A (sl) 2007-06-08 2007-06-08 Aripiprazol hemifumarat, njegova kristalna oblikain postopki za njegovo pripravo
PCT/EP2007/008247 WO2008034628A1 (en) 2006-09-22 2007-09-21 Aripiprazole hemifumarate and process for its preparation

Publications (1)

Publication Number Publication Date
ATE500226T1 true ATE500226T1 (de) 2011-03-15

Family

ID=38962941

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07818336T ATE500226T1 (de) 2006-09-22 2007-09-21 Aripiprazolhemifumarat und verfahren zu dessen herstellung

Country Status (7)

Country Link
EP (1) EP2081904B1 (de)
AT (1) ATE500226T1 (de)
DE (1) DE602007012924D1 (de)
EA (1) EA016840B1 (de)
SI (1) SI2081904T1 (de)
UA (1) UA94624C2 (de)
WO (1) WO2008034628A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2709445T3 (es) 2006-05-16 2019-04-16 Amicus Therapeutics Inc Opciones de tratamiento para la enfermedad de Fabry
EP2233471A1 (de) 2009-02-06 2010-09-29 Adamed Sp. z o.o. Salz aus 7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy}-3,4.dihydro-2(1h)-chinolinon mit 5-sulfosalizyklischer säure und herstellungsverfahren
WO2011032882A1 (en) * 2009-09-15 2011-03-24 Ratiopharm Gmbh Orally disintegrating pharmaceutical dosage form containing aripiprazole
WO2013100878A1 (en) * 2011-12-27 2013-07-04 Mahmut Bilgic Pharmaceutical formulations comprising aripiprazole
WO2014104989A1 (en) * 2011-12-27 2014-07-03 Mahmut Bilgic Pharmaceutical compositions comprising aripiprazole
WO2015067313A1 (en) * 2013-11-07 2015-05-14 Synthon B.V. Orodispersible pharmaceutical compositions comprising aripiprazole
TW201806597A (zh) 2016-07-19 2018-03-01 美商阿米庫斯醫療股份有限公司 治療ert初治的和已經歷ert的患者中之法布瑞氏症

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006528A (en) * 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
US20060223820A1 (en) * 2006-03-21 2006-10-05 Chemagis Ltd. Crystalline aripiprazole salts and processes for preparation and purification thereof

Also Published As

Publication number Publication date
DE602007012924D1 (de) 2011-04-14
WO2008034628A1 (en) 2008-03-27
EP2081904A1 (de) 2009-07-29
EA016840B1 (ru) 2012-07-30
SI2081904T1 (sl) 2011-05-31
EP2081904B1 (de) 2011-03-02
EA200900463A1 (ru) 2009-06-30
UA94624C2 (uk) 2011-05-25

Similar Documents

Publication Publication Date Title
ZA200805939B (en) Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
MX343620B (es) Forma polimorfica de clorhidrato de pridopidina.
IL194871A (en) Compound linking to bir iap site, intermediate compound, process for compound preparation, method for making acceptable pharmaceutical salt, pharmaceutical preparation and use of compound for drug production
ZA201001015B (en) (Carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
SG138588A1 (en) New naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
IL204556A0 (en) (cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
ATE536864T1 (de) Metoprololsuccinat tabletten mit verlängerter freisetzung und verfahren für deren herstellung
IL193339A0 (en) Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
IL193341A0 (en) Novel azacyclyl-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
AP2384A (en) 1,2,4,5-tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them.
ATE500226T1 (de) Aripiprazolhemifumarat und verfahren zu dessen herstellung
AP2011005935A0 (en) New Benzothiadiazepine compounds, a process for their preparation and pharmaceutical compositions comprising them.
IL188069A0 (en) Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof
EA201200616A1 (ru) Производные 2-оксо-1-пирролидинилимидазотиадиазола
EP2666773A8 (de) Organische aminsalze aus azilsartan, herstellungsverfahren dafür und ihre verwendung
WO2011009533A3 (de) 17-hydroxy-17-pentafluorethyl-estra-4,9(10) -dien-11-ethinylphenyl-derivate, verfahren zu deren herstellung und deren verwendung zur behandlung von krankheiten
WO2010079045A3 (en) Crystalline salt forms of flibanserine
WO2008034912A3 (en) Process for the synthesis of clopidogrel and new forms of pharmaceutically acceptable salts thereof
MX349563B (es) Formulacion farmaceutica de fenofibrato nanonizado.
HK1111403A1 (en) New naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
IL209944A (en) Phenyl-Alkyl Paprazine Compounds, Process for Preparation, Pharmaceutical Composition and Drug Containing them
HK1128462A1 (en) Novel method for preparation of ammonium salts of esomeprazole
MX2010006218A (es) Compuestos organicos.
MX2010003056A (es) Polimorfos de valomaciclovir.
EP2222624A4 (de) Derivate von 4-nerolidylcatechol, pharmazeutische zusammensetzungen, die diese enthalten, und verfahren zu deren herstellung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties